Device Trial Radar · NCT03958357
Post Market Clinical Follow-up Study Venezia
Last checked: Nov 20, 2026Latest source record: Apr 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
41
Actual
Start
Apr 10, 2019
Primary completion
Jul 26, 2021
Study completion May 3, 2022
Sponsor
- Lead sponsor
- Nucletron Operations BVNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Factory CRO
- First posted
- May 22, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigational device is the Advanced Gynecological Applicator (AGA) Venezia configuration, an applicator to treat locally advanced stage cervical cancer. The goal of the study is to assess the performance and the unknown risks or complications of the AGA Venezia configuration during clinical use of the applicator.
Conditions
- Cervical Cancer
Interventions
Advanced Gynecological Applicator configurationDevice
The Advanced Gynecological Applicator Venezia configuration is a gynaecological applicator for intracavitary and interstitial brachytherapy. The applicator consists of tubes, caps and templates to place needles, which can be combined to reach a wide range of target areas. The tubes and possibly used needles, guide the radioactive source of the afterloader to the target volume. Dose optimization and dose fractionation is performed with the goal of adapting the dose to the target volume without exceeding the dose volume constraints for the surrounding normal tissues according to the standard cervical cancer treatment of the centre.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance of the AGA Venezia configuration applicator as assessed by the 'Applicator Performance Questionnaire'Time frame: Within one week after each individual insertion. No change is assessed. The procedure is performed per hospital standard. On average, the procedure and applicator insertions are performed twice.
Locations
3 sites in 3 countries. Site status is shown where the registry gives one.
Medical University Vienna
Vienna, Austria
Ludwig-Maximilians - University of Munich
Munich, Germany
University Medical Centre Utrecht
Utrecht, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.